KRTX

329.93 USD
+0.10 (+0.03%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

stock is up 0.06% since 30 days ago. The next earnings date is Jun 25, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 5 June’s closed higher than May.

About

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia.